The KCNJ11 gene variant (Glu23Lys or E23K) where glutamic acid is replaced with lysine at 23rd position in the translated protein had been found to be a potential biomarker for T2DM (Qiu et al. 2014). Here, KCNJ11 is linked to type 2 diabetes mellitus.